Drug repositioning for idiopathic epilepsy using gene expression signature data

Epilepsy is one of the most common neurological disorders, affecting millions of patients with a substantial economic and human burden. About 30-40% of epileptic patients remain un-treated after the therapeutic option. Genetic or idiopathic epilepsy count about 40% of total epilepsy patients, showin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Pawan, Sheokand, Deepak, Grewal, Annu, Saini, Vandana, Kumar, Ajit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465761/
https://www.ncbi.nlm.nih.gov/pubmed/37654844
http://dx.doi.org/10.6026/97320630018845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465761/
https://www.ncbi.nlm.nih.gov/pubmed/37654844
http://dx.doi.org/10.6026/97320630018845

Ejemplares similares